{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:49:23Z","timestamp":1793504963055,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pain Ther"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s40122-024-00603-8","type":"journal-article","created":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T19:02:16Z","timestamp":1715281336000},"page":"481-493","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Tumor Necrosis Factor and Interleukin Modulators for Pathologic Pain States: A Narrative Review"],"prefix":"10.1007","volume":"13","author":[{"given":"Alan D.","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique M.","family":"Perilloux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace C.","family":"Wester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda R.","family":"Ragaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sage V.","family":"Hebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rucha A.","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azem A.","family":"Chami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4545-4523","authenticated-orcid":false,"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,9]]},"reference":[{"issue":"2","key":"603_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/AIA.0b013e318034194e","volume":"45","author":"JM Zhang","year":"2007","unstructured":"Zhang JM, An J. Cytokines, Inflammation and Pain. Int Anesthesiol Clin. 2007;45(2):27\u201337. https:\/\/doi.org\/10.1097\/AIA.0b013e318034194e.","journal-title":"Int Anesthesiol Clin"},{"key":"603_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.788578","author":"LG Pinto","year":"2021","unstructured":"Pinto LG, Pinho-Ribeiro FA, Verri WA. Editorial: cytokines and pain. front Immunol Internet. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.788578.","journal-title":"front Immunol Internet."},{"key":"603_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.03009","author":"AG Vanderwall","year":"2019","unstructured":"Vanderwall AG, Milligan ED. Cytokines in pain: harnessing endogenous anti-inflammatory signaling for improved pain management. Front Immunol [Internet]. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.03009.","journal-title":"Front Immunol [Internet]"},{"issue":"3","key":"603_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/joim.12957","volume":"286","author":"T Crosson","year":"2019","unstructured":"Crosson T, Roversi K, Balood M, Othman R, Ahmadi M, Wang JC, et al. Profiling of how nociceptor neurons detect danger\u2014new and old foes. J Intern Med. 2019;286(3):268\u201389. https:\/\/doi.org\/10.1111\/joim.12957.","journal-title":"J Intern Med"},{"key":"603_CR5","doi-asserted-by":"publisher","first-page":"F1000 Faculty R","DOI":"10.12688\/f1000research.17023.1","volume":"8","author":"J Holbrook","year":"2019","unstructured":"Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott MF. Tumour necrosis factor signalling in health and disease. F1000Research. 2019;8:F1000 Faculty Rev-111. https:\/\/doi.org\/10.12688\/f1000research.17023.1.","journal-title":"F1000Research."},{"issue":"2","key":"603_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.canlet.2012.10.014","volume":"328","author":"WM Chu","year":"2013","unstructured":"Chu WM. Tumor necrosis factor. Cancer Lett. 2013;328(2):222\u20135. https:\/\/doi.org\/10.1016\/j.canlet.2012.10.014.","journal-title":"Cancer Lett"},{"issue":"7","key":"603_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1742-2094-7-27","volume":"16","author":"L Leung","year":"2010","unstructured":"Leung L, Cahill CM. TNF-\u03b1 and neuropathic pain\u2014a review. J Neuroinflammation. 2010;16(7):27. https:\/\/doi.org\/10.1186\/1742-2094-7-27.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"603_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/exnr.1999.7193","volume":"160","author":"A George","year":"1999","unstructured":"George A, Schmidt C, Weishaupt A, Toyka KV, Sommer C. Serial determination of tumor necrosis factor-alpha content in rat sciatic nerve after chronic constriction injury. Exp Neurol. 1999;160(1):124\u201332. https:\/\/doi.org\/10.1006\/exnr.1999.7193.","journal-title":"Exp Neurol"},{"issue":"1","key":"603_CR9","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0006-8993(99)02321-5","volume":"855","author":"VI Shubayev","year":"2000","unstructured":"Shubayev VI, Myers RR. Upregulation and interaction of TNF\u03b1 and gelatinases A and B in painful peripheral nerve injury. Brain Res. 2000;855(1):83\u20139. https:\/\/doi.org\/10.1016\/S0006-8993(99)02321-5.","journal-title":"Brain Res"},{"issue":"1","key":"603_CR10","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.expneurol.2004.11.002","volume":"192","author":"A George","year":"2005","unstructured":"George A, Buehl A, Sommer C. Tumor necrosis factor receptor 1 and 2 proteins are differentially regulated during Wallerian degeneration of mouse sciatic nerve. Exp Neurol. 2005;192(1):163\u20136. https:\/\/doi.org\/10.1016\/j.expneurol.2004.11.002.","journal-title":"Exp Neurol"},{"issue":"18","key":"603_CR11","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1097\/00001756-199611250-00018","volume":"7","author":"R Wagner","year":"1996","unstructured":"Wagner R, Myers RR. Endoneurial injection of TNF-\u03b1 produces neuropathic pain behaviors. NeuroReport. 1996;7(18):2897. https:\/\/doi.org\/10.1097\/00001756-199611250-00018.","journal-title":"NeuroReport"},{"issue":"2","key":"603_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1046\/j.1529-8027.2000.00012.x","volume":"5","author":"LS Sorkin","year":"2000","unstructured":"Sorkin LS, Doom CM. Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat. J Peripher Nerv Syst JPNS. 2000;5(2):96\u2013100. https:\/\/doi.org\/10.1046\/j.1529-8027.2000.00012.x.","journal-title":"J Peripher Nerv Syst JPNS"},{"issue":"10","key":"603_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1212\/wnl.56.10.1371","volume":"56","author":"M Empl","year":"2001","unstructured":"Empl M, Renaud S, Erne B, Fuhr P, Straube A, Schaeren-Wiemers N, et al. TNF-alpha expression in painful and nonpainful neuropathies. Neurology. 2001;56(10):1371\u20137. https:\/\/doi.org\/10.1212\/wnl.56.10.1371.","journal-title":"Neurology"},{"issue":"2","key":"603_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3171\/SPI\/2008\/9\/8\/221","volume":"9","author":"MF Shamji","year":"2008","unstructured":"Shamji MF, Jing L, Chen J, Hwang P, Ghodsizadeh O, Friedman AH, et al. Treatment of neuroinflammation by soluble tumor necrosis factor receptor Type II fused to a thermally responsive carrier. J Neurosurg Spine. 2008;9(2):221\u20138. https:\/\/doi.org\/10.3171\/SPI\/2008\/9\/8\/221.","journal-title":"J Neurosurg Spine"},{"issue":"1","key":"603_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/s0006-8993(01)02743-3","volume":"913","author":"C Sommer","year":"2001","unstructured":"Sommer C, Lindenlaub T, Teuteberg P, Sch\u00e4fers M, Hartung T, Toyka KV. Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy. Brain Res. 2001;913(1):86\u20139. https:\/\/doi.org\/10.1016\/s0006-8993(01)02743-3.","journal-title":"Brain Res"},{"issue":"3","key":"603_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.neulet.2004.12.064","volume":"379","author":"CI Svensson","year":"2005","unstructured":"Svensson CI, Sch\u00e4fers M, Jones TL, Powell H, Sorkin LS. Spinal blockade of TNF blocks spinal nerve ligation-induced increases in spinal P-p38. Neurosci Lett. 2005;379(3):209\u201313. https:\/\/doi.org\/10.1016\/j.neulet.2004.12.064.","journal-title":"Neurosci Lett"},{"issue":"19","key":"603_CR17","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1097\/01.brs.0000141179.58778.6c","volume":"29","author":"T Korhonen","year":"2004","unstructured":"Korhonen T, Karppinen J, Malmivaara A, Autio R, Niinim\u00e4ki J, Paimela L, et al. Efficacy of infliximab for disc herniation-induced sciatica: one-year follow-up. Spine. 2004;29(19):2115\u20139. https:\/\/doi.org\/10.1097\/01.brs.0000141179.58778.6c.","journal-title":"Spine"},{"issue":"1","key":"603_CR18","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/01.anes.0000267518.20363.0d","volume":"107","author":"SP Cohen","year":"2007","unstructured":"Cohen SP, Wenzell D, Hurley RW, Kurihara C, Buckenmaier CC, Griffith S, et al. A double-blind, placebo-controlled, dose-response pilot study evaluating intradiscal etanercept in patients with chronic discogenic low back pain or lumbosacral radiculopathy. Anesthesiology. 2007;107(1):99\u2013105. https:\/\/doi.org\/10.1097\/01.anes.0000267518.20363.0d.","journal-title":"Anesthesiology"},{"key":"603_CR19","unstructured":"Justiz Vaillant AA, Qurie A. Interleukin. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jan 25]. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK499840\/."},{"issue":"13","key":"603_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/OARRR.S291388","volume":"5","author":"A Sebba","year":"2021","unstructured":"Sebba A. Pain: a review of interleukin-6 and its roles in the pain of rheumatoid arthritis. Open Access Rheumatol Res Rev. 2021;5(13):31\u201343. https:\/\/doi.org\/10.2147\/OARRR.S291388.","journal-title":"Open Access Rheumatol Res Rev"},{"issue":"1","key":"603_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/imr.12621","volume":"281","author":"CA Dinarello","year":"2018","unstructured":"Dinarello CA. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8\u201327. https:\/\/doi.org\/10.1111\/imr.12621.","journal-title":"Immunol Rev"},{"issue":"13","key":"603_CR22","doi-asserted-by":"publisher","first-page":"174480691772455","DOI":"10.1177\/1744806917724559","volume":"1","author":"SK Totsch","year":"2017","unstructured":"Totsch SK, Sorge RE. Immune system involvement in specific pain conditions. Mol Pain. 2017;1(13):1744806917724559. https:\/\/doi.org\/10.1177\/1744806917724559.","journal-title":"Mol Pain"},{"issue":"3","key":"603_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.jpain.2010.08.003","volume":"12","author":"CF Kim","year":"2011","unstructured":"Kim CF, Moalem-Taylor G. Interleukin-17 contributes to neuroinflammation and neuropathic pain following peripheral nerve injury in mice. J Pain. 2011;12(3):370\u201383. https:\/\/doi.org\/10.1016\/j.jpain.2010.08.003.","journal-title":"J Pain"},{"issue":"13","key":"603_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.999407","volume":"29","author":"X Jiang","year":"2022","unstructured":"Jiang X, Zhou R, Zhang Y, Zhu T, Li Q, Zhang W. Interleukin-17 as a potential therapeutic target for chronic pain. Front Immunol. 2022;29(13): 999407. https:\/\/doi.org\/10.3389\/fimmu.2022.999407.","journal-title":"Front Immunol"},{"issue":"12","key":"603_CR25","doi-asserted-by":"publisher","first-page":"4125","DOI":"10.1002\/art.37695","volume":"64","author":"F Richter","year":"2012","unstructured":"Richter F, Natura G, Ebbinghaus M, von Banchet GS, Hensellek S, K\u00f6nig C, et al. Interleukin-17 sensitizes joint nociceptors to mechanical stimuli and contributes to arthritic pain through neuronal interleukin-17 receptors in rodents. Arthritis Rheum. 2012;64(12):4125\u201334. https:\/\/doi.org\/10.1002\/art.37695.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"603_CR26","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1007\/s00415-016-8128-x","volume":"263","author":"E Havrdov\u00e1","year":"2016","unstructured":"Havrdov\u00e1 E, Belova A, Goloborodko A, Tisserant A, Wright A, Wallstroem E, et al. Activity of secukinumab, an anti-IL-17A antibody, on brain lesions in RRMS: results from a randomized, proof-of-concept study. J Neurol. 2016;263(7):1287\u201395. https:\/\/doi.org\/10.1007\/s00415-016-8128-x.","journal-title":"J Neurol"},{"issue":"8","key":"603_CR27","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.celrep.2019.10.085","volume":"29","author":"H Luo","year":"2019","unstructured":"Luo H, Liu HZ, Zhang WW, Matsuda M, Lv N, Chen G, et al. Interleukin-17 regulates neuron-glial communications, synaptic transmission, and neuropathic pain after chemotherapy. Cell Rep. 2019;29(8):2384-2397.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.10.085.","journal-title":"Cell Rep"},{"issue":"4","key":"603_CR28","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.jaci.2016.06.033","volume":"138","author":"M Akdis","year":"2016","unstructured":"Akdis M, Aab A, Altunbulakli C, Azkur K, Costa RA, Crameri R, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor \u03b2, and TNF-\u03b1: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984\u20131010. https:\/\/doi.org\/10.1016\/j.jaci.2016.06.033.","journal-title":"J Allergy Clin Immunol"},{"key":"603_CR29","doi-asserted-by":"publisher","unstructured":"Possible role of inflammatory mediators in tactile hypersens...: PAIN [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/journals.lww.com\/pain\/abstract\/2000\/12010\/possible_role_of_inflammatory_mediators_in_tactile.5.aspx DOI: https:\/\/doi.org\/10.1016\/S0304-3959(00)00331-6","DOI":"10.1016\/S0304-3959(00)00331-6"},{"key":"603_CR30","doi-asserted-by":"publisher","unstructured":"Spinal interleukin\u20106 is an amplifier of arthritic pain in the rat. [cited 2024 Jan 26]; Available from: https:\/\/doi.org\/10.1002\/art.34384","DOI":"10.1002\/art.34384"},{"issue":"10","key":"603_CR31","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1002\/jor.22925","volume":"33","author":"T Sainoh","year":"2015","unstructured":"Sainoh T, Orita S, Miyagi M, Sakuma Y, Yamauchi K, Suzuki M, et al. Interleukin-6 and interleukin-6 receptor expression, localization, and involvement in pain-sensing neuron activation in a mouse intervertebral disc injury model. J Orthop Res. 2015;33(10):1508\u201314. https:\/\/doi.org\/10.1002\/jor.22925.","journal-title":"J Orthop Res"},{"key":"603_CR32","unstructured":"Gerriets V, Goyal A, Khaddour K. Tumor Necrosis Factor Inhibitors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Jan 26]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482425\/"},{"key":"603_CR33","doi-asserted-by":"publisher","unstructured":"An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents - Donnelly - 2009 - Annals of the New York Academy of Sciences - Wiley Online Library [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05382.x","DOI":"10.1111\/j.1749-6632.2009.05382.x"},{"key":"603_CR34","unstructured":"Anakinra: Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/anakinra-drug-information?search=anakinra&source=panel_search_result&selectedTitle=1~128&usage_type=panel&kp_tab=drug_general&display_rank=1#F135437"},{"key":"603_CR35","unstructured":"Etanercept (including biosimilars available in Canada): Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/etanercept-including-biosimilars-available-in-canada-drug-information?search=etanercept&source=panel_search_result&selectedTitle=1~149&usage_type=panel&kp_tab=drug_general&display_rank=1#references"},{"key":"603_CR36","unstructured":"Infliximab (including biosimilars): Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/infliximab-including-biosimilars-drug-information?search=infliximab&source=panel_search_result&selectedTitle=1~149&usage_type=panel&kp_tab=drug_general&display_rank=1"},{"key":"603_CR37","unstructured":"Adalimumab (including biosimilars): Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/adalimumab-including-biosimilars-drug-information?search=adalimumab&source=panel_search_result&selectedTitle=1~149&usage_type=panel&kp_tab=drug_general&display_rank=1"},{"key":"603_CR38","unstructured":"Certolizumab pegol: Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/certolizumab-pegol-drug-information?search=certolizumab%20pegol&source=panel_search_result&selectedTitle=1~68&usage_type=panel&kp_tab=drug_general&display_rank=1"},{"key":"603_CR39","unstructured":"Golimumab: Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/golimumab-drug-information?search=golimumab&source=panel_search_result&selectedTitle=1~67&usage_type=panel&kp_tab=drug_general&display_rank=1#F7764845"},{"key":"603_CR40","unstructured":"Sarilumab: Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/sarilumab-drug-information?search=sarilumab&source=panel_search_result&selectedTitle=1~23&usage_type=panel&kp_tab=drug_general&display_rank=1"},{"key":"603_CR41","unstructured":"Tocilizumab (including biosimilars): Drug information - UpToDate [Internet]. [cited 2024 Jan 26]. Available from: https:\/\/www.uptodate.com\/contents\/tocilizumab-including-biosimilars-drug-information?source=auto_suggest&selectedTitle=1~1---1~4---tocili&search=tocilizumab"},{"issue":"10","key":"603_CR42","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00586-012-2183-5","volume":"21","author":"S Ohtori","year":"2012","unstructured":"Ohtori S, Miyagi M, Eguchi Y, Inoue G, Orita S, Ochiai N, et al. Efficacy of epidural administration of anti-interleukin-6 receptor antibody onto spinal nerve for treatment of sciatica. Eur Spine J. 2012;21(10):2079\u201384. https:\/\/doi.org\/10.1007\/s00586-012-2183-5.","journal-title":"Eur Spine J"},{"issue":"11","key":"603_CR43","doi-asserted-by":"publisher","first-page":"1759720X1983115","DOI":"10.1177\/1759720X19831151","volume":"5","author":"L Bessette","year":"2019","unstructured":"Bessette L, Haraoui B, Chow A, Fortin I, Dixit S, Khraishi M, et al. Effectiveness and safety of certolizumab pegol in rheumatoid arthritis patients in Canadian practice: 2-year results from the observational F\u03b1sT-CAN study. Ther Adv Musculoskelet Dis. 2019;5(11):1759720X19831151. https:\/\/doi.org\/10.1177\/1759720X19831151.","journal-title":"Ther Adv Musculoskelet Dis."},{"issue":"6","key":"603_CR44","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/art.39093","volume":"67","author":"MC Genovese","year":"2015","unstructured":"Genovese MC, Fleischmann R, Kivitz AJ, Rell-Bakalarska M, Martincova R, Fiore S, et al. Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a phase III study. Arthritis Rheumatol. 2015;67(6):1424\u201337. https:\/\/doi.org\/10.1002\/art.39093.","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"603_CR45","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.joca.2018.02.899","volume":"26","author":"D Aitken","year":"2018","unstructured":"Aitken D, Laslett LL, Pan F, Haugen IK, Otahal P, Bellamy N, et al. A randomised double-blind placebo-controlled crossover trial of HUMira (adalimumab) for erosive hand OsteoaRthritis\u2014the HUMOR trial. Osteoarthritis Cartilage. 2018;26(7):880\u20137. https:\/\/doi.org\/10.1016\/j.joca.2018.02.899.","journal-title":"Osteoarthritis Cartilage"},{"issue":"4","key":"603_CR46","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1186\/ar3430","volume":"13","author":"SB Cohen","year":"2011","unstructured":"Cohen SB, Proudman S, Kivitz AJ, Burch FX, Donohue JP, Burstein D, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther. 2011;13(4):R125. https:\/\/doi.org\/10.1186\/ar3430.","journal-title":"Arthritis Res Ther"},{"key":"603_CR47","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.sjpain.2017.08.002","volume":"17","author":"AL Hung","year":"2017","unstructured":"Hung AL, Lim M, Doshi TL. Targeting cytokines for treatment of neuropathic pain. Scand J Pain. 2017;17:287\u201393. https:\/\/doi.org\/10.1016\/j.sjpain.2017.08.002.","journal-title":"Scand J Pain"},{"issue":"1","key":"603_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12035-019-01757-9","volume":"57","author":"DP Kuffler","year":"2020","unstructured":"Kuffler DP. Mechanisms for Reducing Neuropathic Pain. Mol Neurobiol. 2020;57(1):67\u201387. https:\/\/doi.org\/10.1007\/s12035-019-01757-9.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"603_CR49","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy EH, De Benedetti F, Takeuchi T, Hashizume M, John MR, Kishimoto T. Translating IL-6 biology into effective treatments. Nat Rev Rheumatol. 2020;16(6):335\u201345. https:\/\/doi.org\/10.1038\/s41584-020-0419-z.","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"603_CR50","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/art.27221","volume":"62","author":"GG Illei","year":"2010","unstructured":"Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K, et al. Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study. Arthritis Rheum. 2010;62(2):542\u201352. https:\/\/doi.org\/10.1002\/art.27221.","journal-title":"Arthritis Rheum"}],"container-title":["Pain and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40122-024-00603-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40122-024-00603-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T15:28:37Z","timestamp":1716391717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40122-024-00603-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,9]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["603"],"URL":"https:\/\/doi.org\/10.1007\/s40122-024-00603-8","relation":{},"ISSN":["2193-8237","2193-651X"],"issn-type":[{"value":"2193-8237","type":"print"},{"value":"2193-651X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,9]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dominique M. Perilloux, Alison M. Hawkins, Grace C. Wester, Amanda R. Ragaland, Sage V. Hebert, Julian Kim, Michael Heisler, Rucha A. Kelkar, Azem A. Chami, Sahar Shekoohi, and Adam M. Kaye have nothing to disclose. Alan Kaye is an Editorial Board member of Pain and Therapy. Alan Kaye was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article is based on previous studies and contains no new studies with human participants or animals performed by any authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}